XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Cover
Jul. 21, 2023
Document Type 8-K/A
Amendment Flag true
Amendment Description This Amendment No. 1 on Form 8-K/A (this “Amendment No. 1”) amends Item 9.01 of the Current Report on Form 8-K filed by AEON Biopharma, Inc. (the “Company”) on July 27, 2023, (the “Original Report”), in which the Company reported, among other events, the completion of the Transactions. This Amendment No. 1 amends Items 9.01(a) and 9.01(b) in the Original Report to include (a) the unaudited condensed consolidated financial statements of AEON Biopharma, Inc., a Delaware corporation formerly known as AEON Biopharma, Inc. (“Old AEON”), as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022, and (b) the unaudited pro forma condensed combined financial information of Priveterra Acquisition Corp. (“Priveterra”) and Old AEON as of and for the six months ended June 30, 2023 and for the year ended December 31, 2022. This Amendment No. 1 does not amend any other item of the Original Report or purport to provide an update or a discussion of any developments at the Company subsequent to the filing date of the Original Report.
Document Period End Date Jul. 21, 2023
Entity File Number 001-40021
Entity Registrant Name AEON Biopharma, Inc.
Entity Central Index Key 0001837607
Entity Tax Identification Number 85-3940478
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 5 Park Plaza,
Entity Address, Address Line Two Suite 1750
Entity Address, City or Town Irvine
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92614
City Area Code 949
Local Phone Number 354-6499
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Elected Not To Use the Extended Transition Period false
Common Stock [Member]  
Title of 12(b) Security Common stock, $0.0001 par value per share
Trading Symbol AEON
Security Exchange Name NYSE
Warrant [Member]  
Title of 12(b) Security Warrants to purchase common stock
Trading Symbol AEON WS
Security Exchange Name NYSE